| Interventional Study to Assess Efficacy and Safety of Velmanase Alfa in Patients With Alpha Mannosidosis (NCT04031066) | Chiesi Farmaceutici S.p.A. | 2021-01-11 |
| Trial on Safety and Efficacy of Velmanase Alfa Treatment in Pediatric Patients With Alpha-Mannosidosis (NCT02998879) | Chiesi Farmaceutici S.p.A. | 2016-12-01 |
| Evaluation of Long-term Efficacy of Treatment With Lamazym (NCT02478840) | Zymenex A/S | 2015-02-01 |
| Clinical Biomarkers in Alpha-mannosidosis (NCT02141503) | Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) | 2014-07-24 |
| MT2013-31: Allo HCT for Metabolic Disorders and Severe Osteopetrosis (NCT02171104) | Masonic Cancer Center, University of Minnesota | 2014-07-10 |
| Lamazym Aftercare Study FR Designed to Provide Treatment for French Patients (NCT01908712) | Chiesi Farmaceutici S.p.A. | 2013-08-01 |
| Lamazym Aftercare Study (NCT01908725) | Chiesi Farmaceutici S.p.A. | 2013-06-01 |
| A Placebo-Controlled Phase 3 Trial of Repeated Lamazym Treatment of Subjects With Alpha-Mannosidosis (NCT01681953) | Zymenex A/S | 2012-08-01 |
| Longitudinal Study of Neurodegenerative Disorders (NCT03333200) | University of Pittsburgh | 2012-01-11 |
| Long-term Efficacy and Safety of Lamazym for the Treatment of Patients With Alpha-Mannosidosis (NCT01681940) | Zymenex A/S | 2012-01-01 |
| Phase I/II Pilot Study of Mixed Chimerism to Treat Inherited Metabolic Disorders (NCT01372228) | Talaris Therapeutics Inc. | 2011-04-01 |
| Safety Study of Recombinant Human Alpha-mannosidase for the Treatment of Patients With Alpha-mannosidosis (NCT01268358) | Zymenex A/S | 2010-10-01 |
| Allogeneic Bone Marrow Transplant for Inherited Metabolic Disorders (NCT01043640) | Masonic Cancer Center, University of Minnesota | 2009-12-01 |
| Longitudinal Studies of the Glycoproteinoses (NCT01891422) | Greenwood Genetic Center | 2009-08-01 |
| Hematopoietic Stem Cell Transplantation (HCT) for Inborn Errors of Metabolism (NCT00668564) | Masonic Cancer Center, University of Minnesota | 2008-03-01 |
| The Natural History of Alpha-Mannosidosis (NCT00498420) | Zymenex A/S | 2007-05-01 |
| Expanded Access to Velmanase Alfa (NCT04959240) | Chiesi Farmaceutici S.p.A. | |